Billable / Specific Code
ICD-10-CM E26.02 is the diagnosis code for Glucocorticoid-remediable aldosteronism. This code falls under the section "Disorders of other endocrine glands" within Chapter 4 — Endocrine, nutritional and metabolic diseases (E00-E89). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where E26.02 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, E26.02 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
E26.02 is the ICD-10-CM diagnosis code for "Glucocorticoid-remediable aldosteronism". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of E26.02 is E26.0 ("Primary hyperaldosteronism"). E26.02 provides a more specific classification within this category.
E26.02 is located in Section E20-E35 — "Disorders of other endocrine glands" within Chapter 4 of the ICD-10-CM Tabular List.
Use E26.02 when the patients documented diagnosis matches "Glucocorticoid-remediable aldosteronism" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Glucocorticoid-remediable aldosteronism is E26.02.
Yes, E26.02 can be used as a primary diagnosis code since it is billable and specific.
E26.02 is in Chapter 4 of the ICD-10-CM Tabular List.
Yes, E26.02 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.